Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: aspirin attending: chief complaint: acute cholecystitis major surgical or invasive procedure: percutaneous cholecystostomy tube placement history of present illness: the patient is 85-year-old female with multiple medical co-morbidities who was admitted to last night for abdominal pain. surgery was consulted this afternoon for finding of gangrenous gallbladder. patient is a poor historian with history of dementia, therefore history was obtain from her daughter and chart. she did complained of ruq abdominal pain during the interview. per history, she has been living at a nursing facility, on the . she was noticed to be in lethargy and decrease responsiveness on . she also complained of abdominal pain and had decreased po intake in the next 2 days. patient was brought to ed on and was given imipenem/cislastatin 500mg iv. she was admitted to hospitalist service with presumed urosepsis and was given ceftazidine 1gm in the icu. a ct scan of abd/pelvis was performed earlier this morning and reported to have edematous gallbladder wall with intra-luminal air this morning. she was verbally limited but denied any fever/chilss. she denied any nausea/vomiting/cp/sob past medical history: afib, utis, pyelonephritis, right ureteral stone s/p stent placement and removal, ra, uterine ca, dementia, hypothyroidism, dm t2, htn, diastolic chf, itp, r retinal detachment social history: - hx of 22ppd smoking history in the past, quit more than 40 years ago, no etoh - lives in nursing home, wheelchair bound - daughters are healthcare proxy - dnr but may intubate if temporary to save her life - confirmed with her daughter family history: mother with cholecystitis, cholecystectomy physical exam: on discharge: afebrile, vss gen: nad, resting comfortably cv: rrr, no m/g/r lungs: ctab abd: soft, nt/nd. perc tube in place, draining to gravity bag. drain site is clean, dry, intact. pertinent results: 05:04pm blood wbc-20.4* rbc-3.82* hgb-8.9* hct-28.9* mcv-76*# mch-23.3*# mchc-30.8* rdw-17.0* plt ct-274 08:25am blood wbc-6.6 rbc-3.96* hgb-9.4* hct-30.7* mcv-77* mch-23.6* mchc-30.5* rdw-16.4* plt ct-275 05:04pm blood pt-18.6* ptt-29.6 inr(pt)-1.7* 07:35am blood pt-19.1* ptt-27.1 inr(pt)-1.7* 05:04pm blood glucose-116* urean-21* creat-0.9 na-138 k-4.6 cl-102 hco3-25 angap-16 08:25am blood glucose-67* urean-17 creat-0.8 na-141 k-4.2 cl-102 hco3-30 angap-13 8:14 pm bile bile, gallbladder aspirate. gram stain (final ): 4+ (>10 per 1000x field): polymorphonuclear leukocytes. 4+ (>10 per 1000x field): gram positive rod(s). 3+ (5-10 per 1000x field): gram negative rod(s). smear reviewed; results confirmed. fluid culture (preliminary): results pending. anaerobic culture (preliminary): brief hospital course: the patient was admitted to the general surgical service for evaluation and treatment on . she was initially admitted to the icu as a prophylactic measure due to the severity of her gallbladder disease. she underwent percutaneous cholecystostomy tube placement on and was started on empiric zosyn. the patient tolerated the procedure well. she remained hemodynamically stable and was transferred to the floor on hd2 neuro: the patient received iv dilaudid intially with good effect and adequate pain control. when tolerating oral intake, the patient was transitioned to oral tylenol with good pain control. after the choleycstostomy tube was placed, patient's pain improved significantly and she had no complaints during the remainder of her stay. cv: the patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. pulmonary: the patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. good pulmonary toilet, early ambulation and incentive spirrometry were encouraged throughout hospitalization. gi/gu/fen: the patient was made npo with iv fluids. after the cholecystostomy tube was placed, the patient's diet was advanced to regular, which was well tolerated. patient's intake and output were closely monitored, and iv fluid was adjusted when necessary. electrolytes were routinely followed, and repleted when necessary. id: the patient's white blood count and fever curves were closely watched for signs of infection. initially the patient's wbc was 20.4, but this trended down to 6.6 on hd3. the patient remained afebrile during her stay. the fluid from the drain showed gnr/gprs, but the cultures were pending at time of discharge. the patient was started on zosyn upon admission and was maintained on this during her stay. she will be sent home with one week of augmentin. the drain was left to gravity bag and will remain this way until the patient follows up with dr. . endocrine: the patient's blood sugar was monitored throughout her stay; insulin dosing was adjusted accordingly. hematology: the patient's complete blood count was examined routinely; the patient received two units of ffp prior to cholecystostomy placement for an inr of 1.7. the patient was restarted on her coumadin when tolerating po intake. prophylaxis: the patient received subcutaneous heparin and venodyne boots were used during this stay; was encouraged to get up and ambulate as early as possible. at the time of discharge, the patient was doing well, afebrile with stable vital signs. the patient was tolerating a regular diet, ambulating, voiding, and pain was well controlled. the patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. medications on admission: ceftrixone-lidocaine 1gm im kit qd, coumadin 2.5mg', acetaminophen 650mg prn, remeron 15mg', dextrose oral gel 1 tube prn, humulin r sq ss, prednisone 5mg qd, lexapro 20mg qd, vitamin d 50,000u qd, alphagan eye drop 1 gtt ou , calcium carbonate 1300mg', aricept 10mg', xalatan eye drop 1 gtt', prilosec 20mg'', timoptic eye drop 1 gtt'', danazol 100mg', synthroid 100mcg', toprol xl 12.5mg', albuterol sulfate neb 2.5mg q6hr prn, atrovent soln inh 0.5mg q6hr prn. discharge medications: 1. acetaminophen 650 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for pain. 2. levothyroxine 50 mcg tablet sig: two (2) tablet po daily (daily). 3. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po bid (2 times a day) as needed for gerd. 4. mirtazapine 15 mg tablet sig: one (1) tablet po hs (at bedtime). 5. escitalopram 10 mg tablet sig: two (2) tablet po daily (daily). 6. brimonidine 0.15 % drops sig: one (1) drop ophthalmic (2 times a day). 7. prednisone 5 mg tablet sig: one (1) tablet po daily (daily). 8. warfarin 2.5 mg tablet sig: one (1) tablet po once daily at 4 pm. 9. metoprolol succinate 25 mg tablet sustained release 24 hr sig: 0.5 tablet sustained release 24 hr po daily (daily). 10. latanoprost 0.005 % drops sig: one (1) drop ophthalmic hs (at bedtime). 11. timolol maleate 0.25 % drops sig: one (1) drop ophthalmic (2 times a day). 12. donepezil 5 mg tablet sig: two (2) tablet po hs (at bedtime). 13. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: one (1) inhalation q6h (every 6 hours) as needed for shortness of breath, wheeze. 14. ipratropium bromide 0.02 % solution sig: one (1) inhalation q6h (every 6 hours) as needed for shortness of breath, wheeze. 15. augmentin 500-125 mg tablet sig: one (1) tablet po three times a day for 7 days. disp:*21 tablet(s)* refills:*0* 16. danazol 100 mg capsule sig: one (1) capsule po once a day. discharge disposition: extended care facility: newbridge on the - discharge diagnosis: acute cholecystitis discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: out of bed with assistance to chair or wheelchair. discharge instructions: please call your doctor or nurse practitioner if you experience the following: *you experience new chest pain, pressure, squeezing or tightness. *new or worsening cough, shortness of breath, or wheeze. *if you are vomiting and cannot keep down fluids or your medications. *you are getting dehydrated due to continued vomiting, diarrhea, or other reasons. signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *you see blood or dark/black material when you vomit or have a bowel movement. *you experience burning when you urinate, have blood in your urine, or experience a discharge. *your pain is not improving within 8-12 hours or is not gone within 24 hours. call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *you have shaking chills, or fever greater than 101.5 degrees fahrenheit or 38 degrees celsius. *any change in your symptoms, or any new symptoms that concern you. . general discharge instructions: please resume all regular home medications , unless specifically advised not to take a particular medication. also, please take any new medications as prescribed. please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. avoid lifting weights greater than lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. avoid driving or operating heavy machinery while taking pain medications. please follow-up with your surgeon and primary care provider (pcp) as advised. incision care: *please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision site. *avoid swimming and baths until your follow-up appointment. *you may shower, and wash surgical incisions with a mild soap and warm water. gently pat the area dry. drain care: *please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody discharge, warm to touch, fever). *note color, consistency, and amount of fluid in the drain. call the doctor, nurse practitioner, or vna nurse if the amount increases significantly or changes in character. *be sure to empty the drain frequently. record the output, if instructed to do so. *you may shower; wash the area gently with warm, soapy water. *keep the insertion site clean and dry otherwise. *avoid swimming, baths, hot tubs; do not submerge yourself in water. *make sure to keep the drain attached securely to your body to prevent pulling or dislocation. followup instructions: tube cholangiogram date/time: 10:00 , radiology provider: , md phone: date/time: 11:30 3, procedure: percutaneous aspiration of gallbladder diagnoses: congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism atrial fibrillation other persistent mental disorders due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus long-term (current) use of anticoagulants rheumatoid arthritis acute cholecystitis immune thrombocytopenic purpura chronic diastolic heart failure 

Answer: The patient is high likely exposed to